Last Update 30 Jul 26
Fair value Increased 5.09%AZE: Margin Recovery And Dividend Visibility Will Support Repriced Risk Outlook
Analysts have nudged their fair value estimate for Azelis Group higher to €13.11 from €12.48, reflecting a slightly more constructive view on revenue growth, profit margins and risk after recent price target increases from €7.50 to €10.50 and from €10.50 to €12. The latest ratings suggest that key risks are now better reflected in the share price.
Analyst Commentary
Recent research on Azelis Group points to a more balanced view of risk and reward, with analysts adjusting fair value assumptions and target prices to reflect updated expectations for execution and growth.
Bullish Takeaways
- Bullish analysts see the current share price as better aligned with identified risks, which supports a fair value range around €10.50 to €12 and underpins the revised €13.11 estimate.
- Recent target price moves toward €12 suggest growing confidence that Azelis Group can deliver on its revenue and margin ambitions without requiring a major re-rating of the stock.
- The shift in stance from more cautious views to neutral positions implies that execution risk on the existing business plan is now viewed as more manageable.
- Analysts who raise targets while keeping neutral ratings often signal that valuation has become more reasonable relative to perceived operational and balance sheet risks.
Bearish Takeaways
- Bearish analysts still hesitate to move to outright positive ratings, which points to remaining concerns around the company’s ability to consistently deliver on growth and profitability assumptions embedded in current targets.
- The use of neutral ratings alongside higher targets indicates a view that upside from here may be more limited if Azelis Group only meets, rather than exceeds, current expectations.
- Retention of Equal Weight style ratings highlights that some analysts see Azelis as fairly valued compared with peers, with no clear catalyst identified for meaningful outperformance.
- The focus on risk already being priced into the shares also signals that any execution slip, such as weaker revenue trends or lower margins than assumed, could quickly put pressure on the revised valuation framework.
What’s in the News for Azelis Group
- Azelis Group NV shareholders approved a gross dividend of €0.226 per share for the fiscal year 2025, equal to a net amount of approximately €0.158 per share after Belgian withholding tax of 30%. Source: AGM announcement.
- The dividend relates to coupon no. 5 and will trade ex dividend on 29 June 2026, with a record date of 30 June 2026. Source: AGM announcement.
- The approved dividend is scheduled to be payable from 1 July 2026 through the company’s paying agent, KBC Bank NV. Source: AGM announcement.
Valuation Changes for Azelis Group
- Fair Value has risen slightly from €12.48 to €13.11, which reflects a more constructive view within the existing valuation framework.
- Discount Rate has fallen slightly from 9.68% to 9.22%, indicating a modest change in assessed risk for Azelis Group.
- Revenue Growth has risen slightly from 3.01% to 3.33%, using updated assumptions for Azelis Group’s top line outlook in euro terms.
- Net Profit Margin has risen slightly from 4.16% to 4.32%, based on refreshed modelling of € earnings relative to sales.
- Future P/E is largely unchanged, moving marginally from 21.41x to 21.18x, which keeps the valuation multiple broadly in the same range.
Key Takeaways
- Strategic acquisitions and a strong M&A pipeline suggest future revenue growth and expanded net margins from realized synergies.
- Investments in digitalization and sustainability could drive operational efficiencies, improving net margins and earnings stability long-term.
- Geopolitical uncertainty, cost inflation, and regional inconsistencies could hinder Azelis Group's revenue growth and profitability, while working capital issues strain cash flow management.
Catalysts
About Azelis Group- Engages in the distribution of specialty chemicals and food ingredients.
- Azelis Group's organic growth turned positive in Q3 and Q4 of 2024, suggesting improving business conditions and momentum that could lift future revenue and earnings if the trend continues.
- The company completed 8 acquisitions during 2024 with a strong focus on its strategic markets and indicated a promising M&A pipeline, which should contribute to future revenue growth and potentially expand net margins as synergies are realized.
- Azelis is seeing a robust recovery in its Life Sciences segment, particularly in the U.S., which is one of its higher-margin areas, indicating potential for improved gross profit margins and earnings.
- The company is investing in digitalization and sustainability initiatives, which could drive operational efficiencies and improve net margins over the long term.
- Azelis' commitment to optimizing its product portfolio, especially in regions like Asia Pacific and Latin America, aligns with strategic focus, suggesting improved gross margins and earnings stability as higher-margin products are prioritized.
Azelis Group Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming Azelis Group's revenue will grow by 3.3% annually over the next 3 years.
- Analysts assume that profit margins will increase from 2.7% today to 4.3% in 3 years time.
- Analysts expect earnings to reach €196.0 million (and earnings per share of €0.79) by about July 2029, up from €111.2 million today. However, there is some disagreement amongst the analysts with the more bullish ones expecting earnings as high as €252.3 million.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 21.2x on those 2029 earnings, down from 24.7x today. This future PE is lower than the current PE for the BE Trade Distributors industry at 24.9x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 9.22%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- The company is experiencing significant geopolitical uncertainty and market volatility, which may affect its ability to maintain stable revenue streams and profit margins.
- Lingering cost inflation, including salary and logistics expenses, and higher distribution costs could potentially squeeze net margins, impacting overall profitability.
- Although the company has shown positive organic growth, it continues to face inconsistent recovery across different regions, with certain areas like China and Australia remaining weak, which could hinder overall revenue growth.
- The company's net profit remains flat, and leverage has increased to 2.9x, suggesting potential financial strain that could affect its ability to finance further growth or increase earnings.
- Working capital challenges, particularly with higher inventory and receivables, are leading to lower free cash flow conversion, which may impact the company's ability to efficiently manage cash and meet financial obligations.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €13.11 for Azelis Group based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €16.0, and the most bearish reporting a price target of just €10.0.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €4.5 billion, earnings will come to €196.0 million, and it would be trading on a PE ratio of 21.2x, assuming you use a discount rate of 9.2%.
- Given the current share price of €11.3, the analyst price target of €13.11 is 13.8% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on Azelis Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
